Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Virtual Skin Model Reveals Secrets of Skin Aging

June 27, 2013 By Spectrum

We constantly grow new skin and slough off the old. Until now, scientists have never agreed on exactly how this works, but new research from the University of Sheffield may provide the answer.

Engineers and biologists at the University of Sheffield have shown how a recent theory– that skin has ‘sleeping’ stem cells which can be woken up when required– best explains how our skin constantly regrows. The research– conducted in collaboration with The Procter & Gamble Company (P&G), makers of Olay, and published in Nature Scientific Reports– has implications for combating the effects of aging and perhaps even skin cancer.

The Sheffield/P&G team developed an “in silico” (computer) model of human skin biology, capturing how the outer layers of the skin are developed and maintained over time. This model simulation or “virtual” skin was then used to test the three most popular theories of how skin cells function to regenerate our skin, the largest human organ, over a three-year period. When the simulation was run according to two of the theories, the virtual skin failed to fully regenerate. Only one theory enabled the virtual skin to still be in good shape after three years, as Dr. Xinshan Li (University of Sheffield Faculty of Engineering) and Dr. Arun Upadhyay (P&G), the lead co-authors explained in their research.

“The theory which seems to fit best says that skin has a population of ‘sleeping’ stem cells, which sit in the lowest layer of the skin but don’t constantly divide to make new cells,” Dr. Li said. “However, these sleeping cells can be called into action if the skin is damaged, or if the numbers of other types of more mature skin cells decrease, ensuring that the skin can be constantly regenerated under all conditions.”

The model showed that we gradually lose these sleeping stem cells over time– which would explain why our ability to regenerate our skin reduces as we age. “Each time we wake up these cells, to heal a wound or replenish stocks of other cells, a few of them don’t go back into sleep mode, so the population slowly reduces,” says Dr. Li. “This explains why older skin is slower to heal and in part why our skin changes as we age. By understanding this mechanism better, it might be possible to find ways to combat the effects of aging on our skin.”

Computer modelling of skin biology is the latest step in the evolution of skin science. It allows scientists to project the activity of tissues like skin that are difficult to follow in live systems for extended periods. Currently, 3-dimensional cultures of engineered human skin are viable for only a few weeks and clinical studies in humans are only practical for a few months. With the development of in silico models scientists can predict for the first time what happens in skin as it ages year by year even as it ages decade by decade.

“These models permit exploration of hypotheses in very short periods of time, relative to the lab based bench work,” says Dr. Upadhyay. “In silico modelling can significantly shorten R&D programs, and help focus subsequent lab or clinical work on the options with the greatest likelihood of succeeding. This is another reason why in silico models are an effective complement to more established research tools and methods.”

The ability to follow virtual skin models over decades may be especially important to skin cancer research. Environmental damage caused by UV exposure or chronic wounding can cause sleeping cells to harbor the mutations which cause skin cancers such as basal cell carcinoma, a very aggressive type of skin cancer.

“The stem cells can harbor mutations throughout the years, but with no effect if they’re still in sleep mode,” explains Dr. Li. “However, when they start to divide to heal a wound for example, this could trigger the cancer. If it’s possible to study this phenomenon for long periods of time it may be possible to find ways to prevent the activation of mutated cells and therefore reduce the risk of developing the disease.”

Other parts of the body, such as the lung or gut lining and the cornea, also regenerate in the same way as our skin. Research is already underway at the University of Sheffield to look at the healing process of the lung lining following asthma attacks.

This study is an excellent example of how computer modelling can enhance our long-term understanding of complex processes such as skin aging. Dr. Upadhyay, a physicist-turned-computational biologist, drew inspiration from the great physicist Richard Feynman in summarizing the study, noting that, “You really don’t understand something until you have built it from scratch. By building the virtual skin model from a few cells into a tissue capable of self-renewal, we have moved a big step in our understanding of stem cells and skin renewal.”

For more information, visit Spectrum.

DeviceTalks Weekly.

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech